Financial Statements — AKTS
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Cash & Equivalents | 82.49 | 371.63 |
| Total Current Assets | 524.54 | 543.94 |
| Property, Plant & Equipment | 15.97 | 15.30 |
| Total Non-current Assets* | 33.06 | 32.86 |
| Total Assets | 557.60 | 576.80 |
| Accounts Payable | 2.53 | 1.23 |
| Total Current Liabilities | 32.13 | 27.91 |
| Total Non-current Liabilities* | 40.63 | 42.78 |
| Total Liabilities | 72.76 | 70.69 |
| Retained Earnings | (199.03) | (174.89) |
| Total Stockholder Equity | 484.84 | 506.11 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 |
|---|
| Total Revenue | 3.38 | 3.23 |
| Research & Development | 25.28 | 20.04 |
| Selling, General & Admin | 7.00 | 5.90 |
| Total Operating Expenses | 32.28 | 25.93 |
| Operating Income | (28.90) | (22.71) |
| Net Income | (24.14) | (18.32) |
| Basic EPS | (0.44) | (0.38) |
| Diluted EPS | (0.44) | (0.38) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Operating Cash Flow | (20.59) | (24.24) |
| Capital Expenditures | 1.26 | 1.85 |
| Free Cash Flow* | (21.85) | (26.10) |
| Investing Cash Flow | (268.71) | 20.54 |
| Financing Cash Flow | 0.16 | 337.55 |
* Derived from reported values
